Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.83T
| $9.57B | 5.37% |
47,042,238
+539,825
| +1% | +$98M |
|
2
Apple
AAPL
$4.72T
| $6.9B | 3.87% |
75,611,980
-1,006,264
| -1% | -$78M |
|
3
Amazon
AMZN
$2.51T
| $6.18B | 3.47% |
44,836,920
-43,620
| -0.1% | -$5.27M |
|
4
Mastercard
MA
$469B
| $3.31B | 1.86% |
11,201,566
-53,240
| -0.5% | -$15M |
|
|
5
Alphabet (Google) Class C
GOOG
$3.89T
| $3.29B | 1.85% |
46,571,800
-4,374,380
| -9% | -$295M |
|
6
Adobe
ADBE
$84.3B
| $3.11B | 1.75% |
7,145,975
-211,453
| -3% | -$78.3M |
|
7
Merck
MRK
$322B
| $2.44B | 1.37% |
33,112,331
+2,397,419
| +8% | +$180M |
|
8
Meta Platforms (Facebook)
META
$1.54T
| $2.42B | 1.36% |
10,643,831
-345,121
| -3% | -$72.1M |
|
9
Salesforce
CRM
$129B
| $2.07B | 1.16% |
11,063,148
-839,122
| -7% | -$141M |
|
10
NVIDIA
NVDA
$5.06T
| $1.83B | 1.02% |
192,203,840
-9,529,960
| -5% | -$77.1M |
|
|
11
Boston Scientific
BSX
$64.8B
| $1.78B | 1% |
50,671,073
+8,101,149
| +19% | +$292M |
|
12
Netflix
NFLX
$287B
| $1.77B | 1% |
38,967,990
-3,532,000
| -8% | -$150M |
|
13
Lam Research
LRCX
$400B
| $1.69B | 0.95% |
52,140,280
+8,024,150
| +18% | +$219M |
|
14
Texas Instruments
TXN
$260B
| $1.63B | 0.91% |
12,825,070
-424,231
| -3% | -$49.5M |
|
|
15
AbbVie
ABBV
$454B
| $1.61B | 0.9% |
16,388,581
+4,872,892
| +42% | +$429M |
|
16
Visa
V
$669B
| $1.55B | 0.87% |
8,048,636
+818,456
| +11% | +$150M |
|
17
UnitedHealth
UNH
$385B
| $1.45B | 0.81% |
4,912,780
+547,506
| +13% | +$157M |
|
18
Home Depot
HD
$324B
| $1.41B | 0.79% |
5,629,900
+52,295
| +0.9% | +$12M |
|
19
Procter & Gamble
PG
$342B
| $1.4B | 0.78% |
11,667,715
+899,662
| +8% | +$105M |
|
20
Microchip Technology
MCHP
$44.2B
| $1.36B | 0.76% |
25,814,124
-2,685,900
| -9% | -$121M |
|
21
Bristol-Myers Squibb
BMY
$126B
| $1.25B | 0.7% |
21,181,941
-489,675
| -2% | -$29.3M |
|
22
Nike
NKE
$60.8B
| $1.21B | 0.68% |
12,300,146
+1,893,243
| +18% | +$175M |
|
23
Crown Castle
CCI
$32.6B
| $1.19B | 0.67% |
7,083,233
-723,581
| -9% | -$117M |
|
24
McDonald's
MCD
$187B
| $1.12B | 0.63% |
6,050,971
-27,236
| -0.4% | -$4.99M |
|
|
CTLT
25
DELISTED
CATALENT, INC.
CTLT
| $1.1B | 0.62% |
14,949,888
-812,060
| -5% | -$55.1M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.